Evidence map›Paper›PMID 35628138›Full record

Trial reportInternational journal of molecular sciences2022

A 4-Week Diet Low or High in Advanced Glycation Endproducts Has Limited Impact on Gut Microbial Composition in Abdominally Obese Individuals: The deAGEing Trial.

Armand M A Linkens, Niels van Best, Petra M Niessen, Nicole E G Wijckmans, Erica E C de Goei, Jean L J M Scheijen, Martien C J M van Dongen, Christel C J A W van Gool, Willem M de Vos, Alfons J H M Houben and 4 more

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03866343 (Restriction of Dietary AGEs to Prevent Diabetes in Overweight Individuals), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03866343 nacompletednot on this map

Restriction of Dietary AGEs to Prevent Diabetes in Overweight Individuals: a Randomized Controlled Trial

TypeinterventionalSponsorMaastricht University Medical CenterRan2018 to 2021Enrolled82ConditionsAdvanced Glycation Endproducts, AGEs, Diet, Insulin Sensitivity/ResistanceArmsDiet low or high in advanced glycation endproducts
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Armand M A LinkensDepartment of Internal Medicine, Maastricht University Medical Center, 6229 ER Maastricht, The Netherlands.ORCID 0000-0001-9296-5878
Niels van BestDepartment of Medical Microbiology, Maastricht University Medical Center, 6229 ER Maastricht, The Netherlands.ORCID 0000-0003-3577-7285
Petra M NiessenDepartment of Internal Medicine, Maastricht University Medical Center, 6229 ER Maastricht, The Netherlands.
Nicole E G WijckmansDepartment of Epidemiology, Maastricht University, 6229 HA Maastricht, The Netherlands.
Erica E C de GoeiDepartment of Epidemiology, Maastricht University, 6229 HA Maastricht, The Netherlands.
Jean L J M ScheijenDepartment of Internal Medicine, Maastricht University Medical Center, 6229 ER Maastricht, The Netherlands.
Martien C J M van DongenDepartment of Epidemiology, Maastricht University, 6229 HA Maastricht, The Netherlands.
Christel C J A W van GoolDepartment of Epidemiology, Maastricht University, 6229 HA Maastricht, The Netherlands.
Willem M de VosLaboratory of Microbiology, Wageningen University, 6708 WE Wageningen, The Netherlands.ORCID 0000-0002-0273-3166
Alfons J H M HoubenDepartment of Internal Medicine, Maastricht University Medical Center, 6229 ER Maastricht, The Netherlands.ORCID 0000-0002-1747-8452
Coen D A StehouwerDepartment of Internal Medicine, Maastricht University Medical Center, 6229 ER Maastricht, The Netherlands.
Simone J M P EussenCARIM School for Cardiovascular Diseases, Maastricht University, 6229 ER Maastricht, The Netherlands.ORCID 0000-0003-0559-6838
John PendersDepartment of Medical Microbiology, Maastricht University Medical Center, 6229 ER Maastricht, The Netherlands.ORCID 0000-0001-9146-5919
Casper G SchalkwijkDepartment of Internal Medicine, Maastricht University Medical Center, 6229 ER Maastricht, The Netherlands.
Maastricht University · NLUniversity of Helsinki · FI

Funding

Dutch Diabetes Research Foundation 2016.00.1865Netherlands Organisation for Health Research and Development 95105002
6 · The paper itself

Abstract

Dietary advanced glycation endproducts (AGEs), abundantly present in Westernized diets, are linked to negative health outcomes, but their impact on the gut microbiota has not yet been well investigated in humans. We investigated the effects of a 4-week isocaloric and macronutrient-matched diet low or high in AGEs on the gut microbial composition of 70 abdominally obese individuals in a double-blind parallel-design randomized controlled trial (NCT03866343). Additionally, we investigated the cross-sectional associations between the habitual intake of dietary dicarbonyls, reactive precursors to AGEs, and the gut microbial composition, as assessed by 16S rRNA amplicon-based sequencing. Despite a marked percentage difference in AGE intake, we observed no differences in microbial richness and the general community structure. Only the Anaerostipes spp. had a relative abundance >0.5% and showed differential abundance (0.5 versus 1.11%; p = 0.028, after low- or high-AGE diet, respectively). While the habitual intake of dicarbonyls was not associated with microbial richness or a general community structure, the intake of 3-deoxyglucosone was especially associated with an abundance of several genera. Thus, a 4-week diet low or high in AGEs has a limited impact on the gut microbial composition of abdominally obese humans, paralleling its previously observed limited biological consequences. The effects of dietary dicarbonyls on the gut microbiota composition deserve further investigation.

Indexed as

Gastrointestinal MicrobiomeGlycation End Products, AdvancedObesityCross-Sectional StudiesDietDouble-Blind MethodHumansRNA, Ribosomal, 16SGlycation End Products, AdvancedRNA, Ribosomal, 16S16S rRNAalpha diversitybeta diversitydietary advanced glycation end productsdietary dicarbonylsdifferential abundancegut microbiotaRCTUPLC-MS/MS

Identifiers

PMID35628138
PMCPMC9141283
OpenAlexW4280628157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.